BLUEPRINT
A BLUEPRINT of Haematopoietic Epigenomes
- Description
BLUEPRINT is a large-scale and high impact research project receiving close to 30 million euro funding from the EU. The BLUEPRINT consortium consisting of 42 leading European universities, research institutes and industry entrepreneurs has been formed with the aim to further the understanding of how genes are activated or repressed in both healthy and diseased human cells. BLUEPRINT will focus on distinct types of haematopoietic cells from healthy individuals and on their malignant leukaemic counterparts. It aims to generate reference epigenomes and study them to advance and exploit knowledge of the underlying biological processes and mechanisms in health and disease.
- Coordinator
- Programme
- FP7
- Duration
- 54 months (October 2011 - March 2016)
- Project funding
- € 29,996,664.00
- Project partners
- 0